Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study

Nathan, SD; Cottin, V; Behr, J; Hoeper, MM; Martinez, FJ; Corte, TJ; Keogh, AM; Leuchte, H; Mogulkoc, N; Ulrich, S; Wuyts, WA; Yao, Z; Ley-Zaporozhan, J; Muller-Lisse, UG; Scholle, FD; Bruggenwerth, G; Busse, D; Nikkho, S; Wells, AU

Nathan, SD (corresponding author), Inova Fairfax Hosp, Inova Heart & Vasc Inst, Adv Lung Dis & Transplant Program, 3300 Gallows Rd, Falls Church, VA 22042 USA.

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021; 40 (6): 494

Abstract

BACKGROUND: Riociguat in Patients with Symptomatic Pulmonary Hypertension associated with Idiopathic Interstitial Pneumonias (RISE-IIP), a randomized,......

Full Text Link